Spyre Therapeutics, Inc.

ORBIMED ADVISORS LLC SYRE

Report date

3/31/2023

Quarter

2023 Q1

Filed

5/15/2023

Shares

1,797,221

Value ($000)

521

Weight

0.0%

2019 Q4 - 2023 Q1 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q1	5/15/2023	521	0.0%	1,797,221	3/31/2023
2022 Q4	2/14/2023	809	0.0%	1,797,221	12/31/2022
2022 Q3	11/14/2022	945	0.0%	1,797,221	9/30/2022
2022 Q2	8/15/2022	908	0.0%	1,797,221	6/30/2022
2022 Q1	5/16/2022	6,799	0.1%	2,956,124	3/31/2022
2021 Q4	2/14/2022	14,042	0.2%	2,956,124	12/31/2021
2021 Q3	11/15/2021	31,923	0.4%	4,015,524	9/30/2021
2021 Q2	8/16/2021	27,948	0.3%	4,015,524	6/30/2021
2021 Q1	5/17/2021	31,803	0.3%	4,015,524	3/31/2021
2020 Q4	2/16/2021	31,602	0.3%	4,015,524	12/31/2020
2020 Q3	11/16/2020	28,470	0.4%	4,015,524	9/30/2020
2020 Q2	8/14/2020	37,144	0.5%	4,015,524	6/30/2020
2020 Q1	5/15/2020	13,353	0.2%	2,865,524	3/31/2020
2019 Q4	2/14/2020	21,893	0.3%	2,865,524	12/31/2019